Reuters logo
BRIEF-Newlink genetics announces FDA orphan-drug designation for Indoximod
2017年10月30日 / 下午1点36分 / 24 天前

BRIEF-Newlink genetics announces FDA orphan-drug designation for Indoximod

Oct 30 (Reuters) - Newlink Genetics Corp

* Newlink Genetics announces FDA orphan-drug designation for Indoximod

* ‍Indoximod was granted orphan-drug designation by U.S. FDA for treatment of patients with stage IIB-IV melanoma​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below